275
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis

, , , , , , , , & show all
Pages 50-55 | Received 23 May 2016, Accepted 18 Aug 2016, Published online: 03 Oct 2016

References

  • Leung JWC. Fundamentals of ERCP. In: Cotton P, editor. Advanced Digestive Endoscopy: ERCP. Malden (MA) Blackwell Publishing; 2005. p. 17–81.
  • ASGE Committee on Training. ERCP core curriculum. Gastrointest Endosc. 2006;63:361–376.
  • Cotton P, Garrow DA, Gallender J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80–88.
  • Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–147.
  • Staritz M, Poralla T, Ewe K, et al. Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut. 1985;26:194–197.
  • Kaufman HS, Shermak MA, May CA, et al. Nitric oxide inhibits resting sphincter of Oddi activity. Am J Surg. 1993;165:74–80.
  • Luman W, Pryde A, Heading RC, et al. Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut. 1997;40:541–543.
  • Carr-Locke DL, Gregg JA, Aoki TT. Effects of exogenous glucagon on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma glucagon. Dig Dis Sci. 1983;28:312–320.
  • Ponce J, Garrigues V, Pertejo V, et al. Effect of intravenous glucagon and glucagon-(1-21)-peptide on motor activity of sphincter of Oddi in humans. Dig Dis Sci. 1989;34:61–64.
  • Biliotti D, Habib FI, De Masi E, et al. Effect of glucagon on sphincter of Oddi motor activity. Digestion. 1989;43:185–189.
  • Lahoti S, Catalano MF, Geenen JE, et al. A prospective, double-blind trial of L-hyoscyamine versus glucagon for the inhibition of small intestinal motility during ERCP. Gastrointest Endosc. 1997;46:139–142.
  • Hogan W, Sherman S, Pasricha P, et al. Sphincter of Oddi manometry. Gastrointest Endosc. 1997;45:342–348.
  • Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.
  • Ding J, Jin X, Pan T, et al. Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials. PLoS One. 2013;8:e75645.
  • Talwar A, Dare C, Pain J. Does topical GTN on the sphincter of Oddi facilitate ERCP? A double-blind randomized control trial. Surg Endosc. 2005;19:902–904.
  • Gocer F, Yaris E, Tuncer M. The action of amyl nitrite and isosorbide dinitrate on the contractility of sphincter of Oddi of guinea-pigs. Gen Pharmacol. 1994;25:995–999.
  • Thillainayagam AV, Mee AS. Rapid and successful cholangiography at ERCP using glyceryl trinitrate (GTN) and glucagon. Gut. 1996;38:F215.
  • Staritz M, Poralla T, Dormeyer HH, et al. Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation. Gastroenterology. 1985;88:1807–1811.
  • Uchida N, Ezaki T, Hirabayashi S, et al. Endoscopic lithotomy of common bile duct stones with sublingual nitroglycerin and guidewire. Am J Gastroenterol. 1997;92:1440–1443.
  • Ghori A, Hallisey M, Nwokolo C, et al. The secret (GTN) of successful ERCP cannulation: a prospective randomised controlled study. J R Coll Surg Edinb. 2002;47:634–637.
  • Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg. 2001;88:1178–1182.
  • Moreto M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc. 2003;57:1–7.
  • Kaffes AJ, Bourke MJ, Ding S, et al. A prospective randomized placebo-controlled trial of transdermal glyceryl trinitrate in ERPC: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc. 2006;64:351–357.
  • Beauchant M, Ingrand P, Favriel JM, et al. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Endoscopy. 2008;40:631–636.
  • Bai Y, Xu C, Yang X, et al. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials. Endoscopy. 2009;41:690–695.
  • Nojgaard C, Hornum M, Elkjaer M, et al. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial. Gastrointest Endosc. 2009;69:e31–e37.
  • Shao LM, Chen QY, Chen MY, et al. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci. 2010;55:1–7.
  • Bhatia V, Ahuja V, Acharya SK, et al. A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol. 2011;45:170–176.
  • Hao JY, Wu DF, Wang YZ, et al. Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo controlled trial. World J Gastroenterol. 2009;15:366–368.
  • Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complications following ERCP: results of a large-scale prospective multicenter study. Endoscopy. 2007;39:793–801.
  • Testoni PA, Mariani A, Giussani A, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010;105:1753–1761.
  • Dumonceau JM, Andriulli A, Elmunzer BJ, et al. European Society of Gastrointestinal Endoscopy. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – updated June 2014. Endoscopy. 2014;46:799–815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.